Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies

Patient’s values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation

(2014) Gregory Lip et al.   THROMBOSIS AND HAEMOSTASIS

Stepwise Screening of Atrial Fibrillation in a 75-Year-Old Population

(2013) Johan Engdahl et al.   CIRCULATION

Management of Patients With Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations)

(2013) Jeffrey L. Anderson et al.   CIRCULATION

Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin

(2013) Martin Zalesak et al.  

iPhone ECG application for community screening to detect silent atrial fibrillation: A novel technology to prevent stroke

(2013) Jerrett K. Lau et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

ADVERSE PROGNOSIS OF ASYMPTOMATIC ATRIAL FIBRILLATION DETECTED INCIDENTALLY: A CASE FOR SCREENING

(2013) S. Ben Freedman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fog on the Crystal Ball? Missing Atrial Fibrillation in Forecasting the Future of Stroke

(2013) Lis Neubeck et al.   STROKE

Adelaide Stroke Incidence Study

(2013) James M. Leyden et al.   STROKE

Forecasting the Future of Stroke in the United States: A Policy Statement From the American Heart Association and American Stroke Association

(2013) B. Ovbiagele et al.   STROKE

Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited

(2013) Staffan Björck et al.   STROKE

Screening to identify unknown atrial fibrillation

(2013) Nicole Lowres et al.   THROMBOSIS AND HAEMOSTASIS

Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation

(2013) Steffi Regpala et al.   THROMBOSIS AND HAEMOSTASIS

Assessing cardiovascular risk in regional areas: the Healthy Hearts – Beyond City Limits program

(2012) Melinda J Carrington et al.   BMC HEALTH SERVICES RESEARCH

Barriers to Warfarin Use for Stroke Prevention in Patients With Atrial Fibrillation in Hong Kong

(2012) Vivian W. Y. Lee et al.   CLINICAL CARDIOLOGY

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Screening for atrial fibrillation above age 65 detects an asymptomatic subset at high risk of stroke

(2012) Bishoy Deif et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Sex Differences in Stroke Risk Among Older Patients With Recently Diagnosed Atrial Fibrillation

(2012) Cynthia A. Jackevicius   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Subclinical Atrial Fibrillation and the Risk of Stroke

(2012) Jeff S. Healey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada

(2012) Michael Sharma et al.   THROMBOSIS AND HAEMOSTASIS

Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation

(2012) Ron Pisters et al.   THROMBOSIS AND HAEMOSTASIS

173 Silent atrial fibrillation in olmsted county: A community-based study

(2011) T.S. Tsang et al.   CANADIAN JOURNAL OF CARDIOLOGY

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study

(2011) Amitava Banerjee et al.   THROMBOSIS AND HAEMOSTASIS

An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality

(2010) E. Aliot et al.   EUROPACE

The health loss from ischemic stroke and intracerebral hemorrhage: evidence from the North East Melbourne Stroke Incidence Study (NEMESIS)

(2010) Dominique A Cadilhac et al.   Health and Quality of Life Outcomes

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE